SIBION

USPTO USPTO 2003 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke SIBION wurde als Wortmarke am 07.02.2003 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 10.05.2005 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails

Markenform Wortmarke
Aktenzeichen 78975805
Registernummer 2950387
Anmeldedatum 07. Februar 2003
Veröffentlichungsdatum 23. März 2004
Eintragungsdatum 10. Mai 2005

Markeninhaber

Karl-Heinz-Beckurts-Strasse 13
52428 Juelich
DE

Markenvertreter

Waren und Dienstleistungen

1 Chemical and biological preparations, namely, extracts of cells and tissues and components thereof for scientific, research and industrial use; nucleic acids, peptides, proteins, cell lines for scientific purposes; diagnostic and analytic preparations for analysis and diagnosis for scientific purposes, namely, for the investigation and characterization of the molecular causes of diseases
9 (Based on 44(e)) Electronic, electric, optical, chemical, biological and biochemical sensors for human, animal and plant material, for eucaryotic cells, for cells from microscopic small biopsies, for cells obtained from tissue samples, for cell culture lines, for chemically fixed tissues, for micrometastatic cells, for bone marrow cells, for body fluids, for stem cells, for cloned single cells and for differentiated stages from specific cells, namely, for biological, chemical, biochemical, biotechnological, medical and pharmaceutical research
42 (Based on 44(e)) Scientific and technological services, namely, diagnosis and analysis of animal and human diseases, cell differentiation of stem cells and other progenitor cells, steps in the development from micrometastatic cells to metastatic cells, characterization of the differentiated stages from specific cells, establishing of validated assay systems including cloning of target cDNA, transfection of target cDNA and implementation of biosensors, primary and secondary drug screening, selectivity screening against related targets, recording the kinetics of dose-response relations, determination of pharmacological parameters, identification of target structures for the development of medicaments, determination of the influence of various substances on the cell growth, proliferation, differentiation and secretion of molecules in various cell types, development of pharmaceuticals and medicaments, development of new technology for others in the fields of biology, chemistry, biochemistry, pharmacy, medicine, and biotechnology, licensing and research work in the fields of biomedicine and the search for pharmaceutically active agents
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1378975805